SLGL 株価分析 — SOL GEL TECHNOLOGIES LTD (Healthcare >> Biotechnology)
SLGL に関するよくある質問
SLGLのPER(株価収益率)は?
SOL GEL TECHNOLOGIES LTD(SLGL)は現在PER 23.99倍で取引されています。
SLGLのROE(自己資本利益率)は?
SOL GEL TECHNOLOGIES LTDのROEは-2.03%です。
SLGLの配当利回りは?
SOL GEL TECHNOLOGIES LTDの配当利回りは0.00%です。
SLGLの品質スコア(Quality Score)は?
当社のAIはSLGLの総合財務品質を100点中38点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
SLGLは今が買い時ですか?
当社AIのタイミングスコアは100点中91点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
SLGLはどのセクターに属しますか?
SOL GEL TECHNOLOGIES LTDはHealthcare >> Biotechnologyセクターに分類されます(NASDAQ市場)
SLGL AI Analysis Summary
Our AI summary for SLGL: SOL GEL TECHNOLOGIES LTD (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 23.99, ROE of -2.03%, a dividend yield of 0.00%. Its financial Quality Score stands at 38/100 — fundamentals below the market average. The AI Timing Score is 91/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 82.25
Price
-2.94
(-3.45%)
Day Change
|
|
|---|
SLGL, ファンダメンタルスコアはnot good ( ファンダメンタル = 38) but テクニカルスコアは ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
ROEの伸びが低い
平均ROEが低い
ROAがROEに比べて低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...
| Deepscope 分析 |
|
42% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 91 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 82.25 |
| PBV / Sector |
5.42 / 5.20
|
| Earning Per Share | -0.31 |
| PE / Sector |
23.99 / 19.97
|
| PEG or PE/Growth / Sector |
0.15 / 1.22
GREAT
|
| Average 1M Daily Value |
3.54 M
GREAT
|
| Average 1W Daily Value |
4.44 M
GREAT
|
| Timing Factors |
|
85% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
60% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-08-01 08:00:29 |
| Symbol | SLGL |
| Name | SOL GEL TECHNOLOGIES LTD |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 3.27 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 278.49 / 9,903.94 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 7 Golda Meir Street, Ness Ziona, Israel, 7403650
Phone: 972 8 931 3433
Website: https://www.sol-gel.com
Sector: Healthcare >> Biotechnology
Description: Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, the United States and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat olmsted syndrome. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
Google